Herpes simplex virus: isolation, cytopathological characterization and antiviral sensitivity
- PMID: 24937819
- PMCID: PMC4056703
- DOI: 10.1590/abd1806-4841.20142574
Herpes simplex virus: isolation, cytopathological characterization and antiviral sensitivity
Abstract
Background: Herpes simplex virus (HSV) infection is an endemic disease and it is estimated that 6095% of the adult population are infected with symptoms that are usually self-limiting, though they can be serious, extensive and prolonged in immunocompromised individuals, highlighted by the emergence of drug-resistant strains. The study of the wild-type HSV strains based on the cytopathogenic features and its antiviral sensitivity are important in the establishment of an antivirogram for controlling the infection.
Objective: This study sought to isolate and examine the cytopathological characteristics of circulating strains of the Herpes simplex virus, from clinical specimens and their sensitivity to commercially available antiherpesvirus drugs, acyclovir, phosphonophormic acid and trifluridine.
Methods: Herpes simplex virus isolation, cytopathological features and antiviral sensitivity assays were performed in cell culture by tissue culture infectious dose or plaque forming unit assay.
Results: From twenty-two clinical specimens, we isolated and adapted nine strains. Overall, the cytopathic effect was detected 24 h post-infection (p.i.) and the presence of syncytia was remarkable 48 h p.i., observed after cell staining. Out of eight isolates, four developed plaques of varying sizes. All the isolates were sensitive to acyclovir, phosphonophormic and trifluridine, with the percentage of virus inhibition (%VI) ranging from 49.7-100%.
Conclusions: The methodology for HSV isolation and characterization is a straightforward approach, but the drug sensitivity test, regarded as being of great practical importance, needs to be better understood.
Conflict of interest statement
Conflict of Interest: None.
Figures



Similar articles
-
[In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?].Enferm Infecc Microbiol Clin. 2002 Jan;20(1):25-7. doi: 10.1016/s0213-005x(02)72727-4. Enferm Infecc Microbiol Clin. 2002. PMID: 11820977 Spanish.
-
Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.J Antimicrob Chemother. 1999 Nov;44(5):705-8. doi: 10.1093/jac/44.5.705. J Antimicrob Chemother. 1999. PMID: 10552991
-
Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.J Infect Dis. 1999 Aug;180(2):487-90. doi: 10.1086/314900. J Infect Dis. 1999. PMID: 10395866
-
[Resistance of herpes simplex viruses to antiviral drugs].Pathol Biol (Paris). 1993 Feb;41(2):172-7. Pathol Biol (Paris). 1993. PMID: 8392160 Review. French.
-
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.J Acquir Immune Defic Syndr (1988). 1994 Mar;7(3):254-60. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8106965 Review.
Cited by
-
Human herpesvirus type 1 and type 2 disrupt mitochondrial dynamics in human keratinocytes.Arch Virol. 2018 Oct;163(10):2663-2673. doi: 10.1007/s00705-018-3890-y. Epub 2018 Jun 5. Arch Virol. 2018. PMID: 29872950 Free PMC article.
-
Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections.Sci Rep. 2022 Jan 25;12(1):1345. doi: 10.1038/s41598-022-05188-w. Sci Rep. 2022. PMID: 35079057 Free PMC article.
References
-
- Kuo YC, Lee YC, Leu YL, Tsai WJ, Chang SC. Efficacy of orally administered Lobelia chinensis extracts on herpes simplex virus type 1 infection in BALB/c mice. Antiviral Res. 2008;80:206–212. - PubMed
-
- Griffiths PD. Herpesviruses. Medicine. 2009;37:668–672.
-
- Roizman B, Knipe DM, Whitley RJ. Herpes Simplex Virus. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 2502–2601.
-
- Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplex viruses 1 and 2. Dermatol Clin. 2002;20:249–266. - PubMed
-
- Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Res. 2004;61:73–81. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources